title: Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy.
authors.affiliation: Department of Epidemiology and Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Gange
authors.forename: Bryan
authors.initials: B
authors.lastname: Lau
authors.forename: John
authors.initials: J
authors.lastname: Phair
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Riddler
authors.forename: Roger
authors.initials: R
authors.lastname: Detels
authors.forename: Joseph B
authors.initials: JB
authors.lastname: Margolick
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003906:Developing Countries; D005500:Follow-Up Studies; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D018579:Patient Selection
chemical_list: D019380:Anti-HIV Agents; D006454:Hemoglobins